ORG Wealth Partners
ADPT icon

ORG Wealth Partners’s Adaptive Biotechnologies ADPT Stock Holding History

ORG Wealth Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$780 Buy
+27
New +$663 ﹤0.01% 1858

Other funds holding ADPT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

ORG Wealth Partners's ADPT Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 27 shares worth $780. The stake represents ﹤0.01% of the portfolio and ranks #1858 among its holdings.

244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • ORG Wealth Partners held 27 shares of Adaptive Biotechnologies worth $780 as of Q3 2026.
  • Adaptive Biotechnologies was a new ORG Wealth Partners position in Q3 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #1858 holding.
  • 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.